Core Viewpoint - The stock of Shaanxi Meibang Pharmaceutical Group Co., Ltd. has experienced significant trading volatility, with a cumulative increase of 33.0917% over three consecutive trading days since July 17, 2025, prompting a risk warning for investors [1][2]. Group 1: Company Operations - The company specializes in the research, production, and sales of pesticide products, as well as agricultural technology promotion and services, and its production and operations are currently normal with no significant changes in its main business or external environment [1]. Group 2: Market Trading Risks - Since July 17, 2025, the company's stock has been subject to trading restrictions due to abnormal fluctuations, with a notable increase in stock price leading to a warning for investors to make rational decisions and invest cautiously [2]. Group 3: Media Reports and Market Rumors - The company has conducted a self-examination and found no media reports or market rumors that could significantly impact its stock price, nor has it been involved in any market hot concepts [2]. Group 4: Other Risk Alerts - The company disclosed a shareholder reduction plan on June 4, 2025, which is being executed in accordance with regulations, and there are no violations related to the reduction of shares [2].
美邦股份: 陕西美邦药业集团股份有限公司关于公司股票交易风险提示公告